Inhibition by nitric oxide of the repair protein, o-DNA-methyltransferase

Carcinogenesis

Volumn 15, Issue 3, 1994, Pages 443-447

  Laval, Francoise ^a   Wink, David A ^b,c  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Laboratory of Viral Carcinogenesis   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DIETHYL 2 HYDROXY 2 NITROSOHYDRAZINE; HYDRAZINE DERIVATIVE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DECOMPOSITION; DNA REPAIR; ENZYME ACTIVITY; ENZYME INHIBITION; MACROMOLECULE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT;

ANIMAL; CARMUSTINE; CYSTEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; METHYLTRANSFERASES; NITRIC OXIDE; NITROSO COMPOUNDS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; RATS; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0028181674     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/15.3.443     Document Type: Article

References (31)

1. Moncada, S., Palmer, R.M.J. and Higgs, E.A. (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109-142.
2. Collier, J. and Vallance, P. (1991) Physiological importance of nitric oxide. Br. Med. J., 302, 1289-1290.
3. Wink, D.A., Osawa, Y., Darbyshire, J.F., Jones, C.R., Eshenaur, S.C. and Nims, R.W. (1993) Inhibition of cytochrome F450 by nitric oxide and a nitric- oxide releasing agent. Arch. Biochem. Biophys., 300, 115-123.
4. Wink, D.A., Kasprzak, K.S., Maragos, C.M., Elespuru, R.K., Misra, M., Dunams, T.M., Gebula, T.A., Koch, W.H., Andrews, A.W., Allen, J.S. and Keefer, L.K. (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science, 254, 1001-1003.
5. Nguyen, T., Brunson, D., Crcspi, C. L., Penman, B.W., Wishnok, J.S. and Tannenbaum, S.R. (1992) DNA damage and mutation in human cells exposed to nitric oxide. Proc. Natl Acad. Sci. USA, 89, 3240-3244.
6. Isomura, K., Chikahira, M., Teranishi, K. and Hamada, K. (1984) Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutat. Res., 136, 119-125.
7. Arroyo, P.L., Hatch-Pigott, V., Mower, H.F. and Cooney, R.V. (1992) Induction of mutations and chromosome aberrations in lung cells following in vivo exposure of rats to nitrogen oxides. Mutat. Res., 281, 193-202.
8. Stamlerd, S., Simon, D.L., Osbome, J.A., Mullins, M.E., Jarald, O., Michel, T., Singel, D.L. and Loscalzo, J. (1992) S-Nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl Acad. Sd. USA, 89, 444-448.
9. Molina, Y., Vedia, S., McDonald, B., Reep, B., Brune, B., Di Silvio, M., Billiar, T.R. and Lapetina, E.G. (1992) Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J. Biol Chem., 267, 24929-24932.
10. Ling-Ling, C., Nakamura, T., Nakatsu, Y., Sakumi, K., Hayakawa, H. and Sekiguchi, M. (1992) Specific amino acid sequences required for O^-methylguanine-DNA-methyltransferase activity: analyses of three residues at or near the methyl acceptor site. Carcinogenesis, 13, 837-843.
11. Mitchell, E.B., Moschel, R.C. and Dolan, M.E. (1992) Effect of C^-benzylguanine on the sensitivity of human tumour xenografts to l, 3-bis(2-chloroethyl)-l-nitrosourea and on DNA interstrand cross-links. Cancer Res., 52, 1171-1175.
12. Pegg, A.E. and Byers, T.L. (1992) Repair of DNA containing 06-alkylguanine. FASEB J., 6, 2302-2310.
13. Maragos, C.M., Moriey, D., Wink, D.A., Dunams, T.M., Saavedra, J.E., Hoffman, A., Bove, A.A., Isaac, L., Hrabie, J.A. and Keefer, L.K. (1991) Complexes of ' NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J. Med Chem., 34, 3242-3247.
14. Moriey, D., Maragos, C.M., Zhang, X.-Y., Biognon, M., Wink, D.A. and Keefer, L.K. (1993) Mechanism of vascular relaxation induced by nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilators. J. Cardiovasc. Pharmacol., 21, 670-676.
15. Rahden-Staron, Y. and Laval, F. (1991) cDNA cloning of the rat 06-methylguanine-DNA-methyltransferase. Biochem. Biophys. Res. Common., 177, 597-602.
16. Koike, G., Malri, H., Takeya, H., Hayakawa, M. and Sekiguichi, M. (1990) Purification, structure, and biochemical properties of human C^-methylguanine-DNA methyltransferase. J. Biol. Chem., 265, 14754-14762.
17. Boiteux, S. and Laval, F. (1985) Repair of O^-methylguanine, by mammalian cell extracts, in alkylated DNA and poly(dG-m’dC) in B and Z forms. Carcinogenesis, 6, 805-807.
18. Habraken, Y. and Laval, F. (1991) Enhancement of l, 3-bis(2-chloroethyl)-l- nitrosourea resistance by 7-irradiation or drug pretreatment in rat hepatoma cells. Cancer Res., 51, 1217-1220.
19. Ignarro, L.J., Lippton, H., Edwards, J.C., Baricos, W.H., Hyman, A., Kadowitz, P.J. and Gruetter, C.A. (1981) Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharm. Exp. Ther., 218, 739-749.
20. Myers, P.R., Minor, R.L., Guerra, R., Bates, J.N. and Harrison, D.G. (1990) Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature, 345, 161-163.
21. Wink, D.A., Daibyshire, J.F., Nims, R.W., Saavedra, J.E. and Foid, J.C. (1993) Reactions of the bioregulatory agent nitric oxide in oxygenated aqueous media: determination of the kinetics for oxidation and nitrosation by intermediates generated in the NO/Oj reaction. Chem. Res. Toxicol., 6, 20-24.
22. Pryor, W.A., Church, D.F., Govindan, C.K. and Crank, G. (1982) Oxidation of thiols by nitric oxide and nitrogen dioxide: synthetic utility and toxicological implications. J. Org. Chem., 47, 156-159.
23. Nakahara, K., Tanimoto, T., Hatano, K.-I., Usuda, K. and Shoun, H. (1993) Cytochrome P450 55A1 (P450dNIR) acts as nitric oxide reductase employing NADH as the direct electron donor. J. Biol. Chem., 268, 8350-8356.
24. Clarkson, R.B., Norby, S.W., Smirnov, A., Vahidi, B.N., Nims, R.W. and Wink, D.A. (1993) Direct measurement of intracellular accumulation and mitochondrial consumption of nitric oxide using a novel electron paramagnetic resonance technique. Submitted for publication.
25. Erickson, L.C., Laurent, G., Sharkey, N.A. and Kohn, K.W. (1980) DNA cross¬linking and monoadduct repair in nitrosourea-treated human tumour cells. Nature, 288, 727-729.
26. Kanner, J., Harel, S. and Granit, R. (1992) Inhibition of cyclooxygenase and lipoxygenase by nitric oxide. Lipids, 27, 46-49.
27. Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A. and Freeman, B.A. (1990) Apparent hydroxyl radical production by peroxynitrtite: implications for endothelial injury from nitric oxide and superoxide. Proc. Nad Acad Sd. USA, 87, 1620-1624.
28. Ischiropoulos, H., Zhu, L. and Beckman, J.S. (1992) Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys., 298, 446-451.
29. Liu, R.H., Baldwin, B., Tennant, B.C. and Hotchkiss, J.H. (1991) Elevated formation of nitrate and W-nitrosodimethylamine in woodchucks (Marmota monax) associated with chronic woodchuck hepatitis virus infection. Cancer Res., 51, 3925-3929.
30. Liu, R.H., Jacob, J.R., Tennant, B.C. and Hotchldss, T H. (1992) Nitrite and nitrosamine synthesis by hepatocytes isolated from normal woodchucks (Marmota monax) and woodchucks chronically infected with woodchuck hepatitis virus. Cancer Res., 52, 4139-4143.
31. Marietta, M.A. (1988) Mammalian synthesis of nitrite, nitrate, nitric oxide and jV-nitrosating agents. Chem. Res. Toxicol., 1, 249-257.